The Center for Emerging Viral Threats at LSUHS recently sequenced the first instances in Louisiana of the XBB.1.16 and XBB.1.9.1 variants. "Detecting these very recently emerging variants demonstrates the robustness of our efforts,” said Krista Queen, PhD, Director of Viral Genomics and Surveillance.
The Dept. of Microbiology and Immunology is saddened to share the news of the passing of our esteemed colleague, Kenneth Peterson, PhD, who during his 35 years of service at LSUHS earned a reputation of being an excellent teacher and scientist.
The publication, “Topical Cannabidiol is Well Tolerated in Individuals with a History of Elite Physical Performance and Chronic Lower Extremity Pain,” found that topical CBD was tolerated with little adverse side effects by the study’s population.
Vax Matters - Dr. Jeremy Kamil, Associate Professor of Microbiology and Immunology at LSUHS, shares answers to why viruses change, bringing his wealth of knowledge in virus and disease spread.
LSU - LSU adds key expertise across the state to improve cancer outcomes in Louisiana by supporting top research talent to solve some of the biggest challenges in cancer care for patients and families.
In trying to identify those factors that ultimately determine whether the brain cells remain alive or die off following cardiac arrest, Dr. Hui-Chao (Reggie) Lee discovered a novel enzyme in the brain that occurs much more often in brain neurons that are susceptible to reduced blood flow.
LSUHS is 1 of 25 sites selected to participate in the Surgical Timing and Rehabilitation (STaR) trial, a $4.5 million multicenter trial that is sponsored by the Department of Defense and contracted through the University of Pittsburgh, to investigate timing of multi-ligament knee surgery.
Psych Congress Network - Drs. Alan David Kaye and Elyse Cornett Bradley, professor and assistant professor, respectively, in the Department of Anesthesiology at LSUHS, discuss prevention-based TD treatment.
KTAL6 - The new Biological Safety Level three laboratory is currently being built at LSU Health Shreveport. It will allow the institution to do more research on infectious diseases. According to Chris Kevil, the Vice Chancellor for Research, the idea came during the height of the coronavirus pandemic.
On Thursday, February 23, 2023 LSU Health Shreveport (LSUHS) held the 5th Annual Research Celebration, where members of the community and LSUHS employees and students were invited to hear about the past year's accomplishments of the LSU Health Shreveport Office for Research.
LSUHS has partnered with The Michael J. Fox Foundation for Parkinson’s Research to become one of five sites participating in the Black and African American Connections to Parkinson’s Disease study.
Shreveport Times - Dr. Wayne Orr, Professor and Director of the Center for Cardiovascular Diseases and Sciences said, "the Center is a group of faculty members across multiple departments who work together to build a nationally competitive research group here in Shreveport."
Earlier this week, CCDS hosted the 2nd Annual Feist Cardiovascular Research Symposium. The symposium concluded with a poster session and awards presentation.
Medscape - Alexandre Malek, MD, assistant professor of medicine at LSUHS, pointed to "a growing number of preclinical studies evaluating the role of vaccines as adjunct to immunotherapy to overcome cancer resistance by converting cold tumors to hot." That research includes a study of a seasonal influenza vaccine and another of adenoviral based-vaccines.
Louisiana Radio Network - After a recent report from the LSUHS Louisiana Addiction Research Center showing Shreveport’s wastewater contained double the amount of methamphetamine than anywhere else in the country, many were shocked.